Cell Therapies
Total Trials
14
As Lead Sponsor
7
As Collaborator
Total Enrollment
3,245
NCT05152355
Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients
Phase: Phase 4
Role: Collaborator
Start: Apr 22, 2019
Completion: May 9, 2021
NCT06964711
GW117 ODT (Orally Disintegrating Tablets) Safety and Pharmacokinetics Study in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 12, 2021
Completion: Mar 24, 2023
NCT05159947
SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
Phase: Phase 3
Start: Jan 20, 2022
Completion: Jan 10, 2024
NCT05402852
Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women
Start: Jun 1, 2022
Completion: Dec 31, 2023
NCT06796868
A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder
Phase: Phase 2
Start: Jul 7, 2022
Completion: Oct 12, 2023
NCT05764668
Efficacy and Safety of Zihua Wenfei Granules in Treatment of Postinfectious Cough (Wind-cold Invading Lungs Syndrome)
Start: Nov 15, 2022
Completion: Aug 31, 2024
NCT06416774
A Clinical Study of 68Ga-HX01 Injection for PET Imaging
Start: Dec 29, 2022
Completion: Oct 30, 2023
NCT06277167
A Phase I Study in Healthy Participants
Start: Jan 7, 2023
Completion: Apr 21, 2023
NCT06278389
Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants
Start: Jan 24, 2024
Completion: Apr 23, 2024
NCT07038941
Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
Start: Mar 19, 2024
Completion: Jun 2, 2024
NCT06456684
AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease
Phase: N/A
Start: Apr 12, 2024
Completion: Dec 31, 2026
NCT06708156
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
Start: Jun 15, 2024
Completion: Dec 31, 2027
NCT06719310
Phase Ib/IIa Clinical Study of ACC017 Tablets
Phase: Phase 1/2
Start: Aug 28, 2024
Completion: Nov 30, 2025
NCT07076706
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
Start: Dec 5, 2024
Completion: Jan 31, 2026
Loading map...